U.S. health officials are closely monitoring a recent Andes hantavirus outbreak linked to a luxury cruise ship after three people died earlier this month. The White House and Health Secretary Robert F. Kennedy Jr. are receiving daily updates on the situation as authorities work to prevent further spread of the deadly virus.
According to U.S. Centers for Disease Control and Prevention (CDC) Acting Director Jay Bhattacharya, there are currently no confirmed hantavirus cases in the United States, and officials say the overall public health risk remains low. However, 41 U.S. residents are under observation for possible exposure to the Andes virus. Among them, 18 passengers had already returned to the United States before the outbreak was officially identified. These individuals are now being quarantined in Nebraska and Atlanta as a precautionary measure.
The CDC has issued updated guidance to help health agencies identify and monitor people who may have been exposed during the cruise. Dr. David Fitter, who is leading the CDC’s hantavirus response team, explained that individuals who were onboard the ship between April 6 and May 10 are considered high-risk contacts. The first known patient reportedly became ill on April 6, while the last passenger left the vessel on May 10.
Additional high-risk individuals include anyone who had close and prolonged contact with infected patients, including exposure to bodily fluids or sitting near infected travelers during flights. Health officials stressed that Andes hantavirus does not spread easily between people, unlike more contagious respiratory viruses.
The CDC recommends that high-risk contacts remain at home for six weeks, avoid unnecessary interaction with others, and immediately isolate themselves if symptoms appear. Public health experts continue monitoring the outbreak closely as concerns grow over the government’s initial response and broader preparedness for emerging infectious diseases in 2026.


Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
US Waives $320M Egypt Military Aid Conditions After Iran War Role
US Grants Aurora Five-Year Exemption for Self-Driving Trucks
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
UK Warned Over Growing Reliance on US Cloud Providers
Israel Tightens Pilot Security After Flydubai Incident
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Trump Plans Diesel Tax Relief as Fuel Prices Hit Record Highs
New York Declares Measles Disaster Emergency as Cases Surge
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
3 clinical-grade skincare creams you really shouldn’t buy online
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Crypto Rallies as CLARITY Act Failure Opens Door to Faster SEC Rules 



